Mediwelcome Healthcare Management & Technology (HKSE:02159) Beneish M-Score: -2.28 (As of Jul. 02, 2026)


HKSE:02159 Mediwelcome Healthcare Management & Technology Inc HKSE:02159
54 GF Score
Price HK$1.62
GF Value HK$0.69
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Mediwelcome Healthcare Management & Technology Beneish M-Score?

Mediwelcome Healthcare Management & Technology HKSE:02159 54 Beneish M-Score is -2.28 as of Jul. 02, 2026. GuruFocus rates HKSE:02159 with a GF Score™ of 54/100 and a GF Value™ of HK$0.69 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Mediwelcome Healthcare Management & Technology ranks worse than 71% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.28 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Mediwelcome Healthcare Management & Technology's Beneish M-Score or its related term are showing as below:

HKSE:02159' s Beneish M-Score Range Over the Past 10 Years
Min: -3.79   Med: -2.51   Max: -1.48
Current: -2.28

During the past 9 years, the highest Beneish M-Score of Mediwelcome Healthcare Management & Technology was -1.48. The lowest was -3.79. And the median was -2.51.


Mediwelcome Healthcare Management & Technology Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Mediwelcome Healthcare Management & Technology's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mediwelcome Healthcare Management & Technology Beneish M-Score Chart

Mediwelcome Healthcare Management & Technology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -1.57 -3.47 -3.10 -3.79 -2.28

Mediwelcome Healthcare Management & Technology Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.10 0.00 -3.79 0.00 -2.28

HKSE:02159 vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mediwelcome Healthcare Management & Technology Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mediwelcome Healthcare Management & Technology's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Mediwelcome Healthcare Management & Technology's Beneish M-Score falls into.


HKSE:02159
54GF Score
Mediwelcome Healthcare Management & Technology Inc HKSE:02159
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mediwelcome Healthcare Management & Technology Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Mediwelcome Healthcare Management & Technology for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.4033+0.528 * 0.7838+0.404 * 1.2174+0.892 * 1.506+0.115 * 1.2973
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7223+4.679 * 0.032143-0.327 * 0.7178
=-2.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$33.5 Mil.
Revenue was HK$517.0 Mil.
Gross Profit was HK$104.6 Mil.
Total Current Assets was HK$172.5 Mil.
Total Assets was HK$210.4 Mil.
Property, Plant and Equipment(Net PPE) was HK$9.3 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$5.4 Mil.
Selling, General, & Admin. Expense(SGA) was HK$70.4 Mil.
Total Current Liabilities was HK$91.2 Mil.
Long-Term Debt & Capital Lease Obligation was HK$2.8 Mil.
Net Income was HK$11.0 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$4.3 Mil.
Total Receivables was HK$55.2 Mil.
Revenue was HK$343.3 Mil.
Gross Profit was HK$54.5 Mil.
Total Current Assets was HK$171.7 Mil.
Total Assets was HK$207.2 Mil.
Property, Plant and Equipment(Net PPE) was HK$12.3 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$11.1 Mil.
Selling, General, & Admin. Expense(SGA) was HK$64.7 Mil.
Total Current Liabilities was HK$125.0 Mil.
Long-Term Debt & Capital Lease Obligation was HK$4.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(33.513 / 517.032) / (55.172 / 343.318)
=0.064818 / 0.160702
=0.4033

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(54.456 / 343.318) / (104.629 / 517.032)
=0.158617 / 0.202365
=0.7838

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (172.464 + 9.344) / 210.436) / (1 - (171.746 + 12.32) / 207.222)
=0.136041 / 0.111745
=1.2174

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=517.032 / 343.318
=1.506

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(11.05 / (11.05 + 12.32)) / (5.359 / (5.359 + 9.344))
=0.472828 / 0.364483
=1.2973

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(70.368 / 517.032) / (64.69 / 343.318)
=0.1361 / 0.188426
=0.7223

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2.786 + 91.235) / 210.436) / ((4.018 + 124.967) / 207.222)
=0.446791 / 0.622448
=0.7178

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(11.034 - 0 - 4.27) / 210.436
=0.032143

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Mediwelcome Healthcare Management & Technology has a M-score of -2.28 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.28 mean?
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Beneish M-Score of -2.28 as of Jul. 02, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #448 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 71%.
Is Mediwelcome Healthcare Management & Technology's Beneish M-Score too high?
Mediwelcome Healthcare Management & Technology's current Beneish M-Score is -2.28. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #448 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Beneish M-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #448 out of 631 companies for Beneish M-Score. This places Mediwelcome Healthcare Management & Technology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. Mediwelcome Healthcare Management & Technology's current Beneish M-Score is -2.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.69, compared to a current price of HK$1.62 — trading 134.8% above its estimated fair value. The current Beneish M-Score is -2.28. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Beneish M-Score is -2.28 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?

Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued. The current stock price of HK$1.62 is trading 134.8% above its estimated GF Value™ of HK$0.69. GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02159:

  • Beneish M-Score: -2.28
  • GF Value™: HK$0.69 vs. price of HK$1.62 (134.8% above fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mediwelcome Healthcare Management & Technology Business Description

Address Wangjingdongyuan Zone 4, Wangjing East Park, 17th Floor, Block B, Greenland Center, Chaoyang District, Beijing, CHN, 100101
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
54GF Score

Get the complete analysis for HKSE:02159

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.62
Price
HK$0.69
GF Value